Literature DB >> 20806292

A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2.

Silvia Piconese1, Paola Pittoni, Alessia Burocchi, Andrea Gorzanelli, Alessandra Carè, Claudio Tripodo, Mario P Colombo.   

Abstract

OX40 stimulation is known to enhance activation of effector T cells and to inhibit induction and suppressive function of Treg. Here we uncovered a novel role of OX40 in sustaining Treg competitive fitness in vivo, during repopulation of lymphopenic hosts and reconstitution of BM chimeras. Defective expansion of OX40-null Treg diminished their ability to suppress inflammation in a model of lymphopenia-driven colitis. OX40-mediated promotion of Treg fitness spanned beyond lymphopenic environments, as endogenous Treg in OX40-null mice showed decreased accumulation during thymic development, enhanced susceptibility to antibody-mediated depletion and defective turnover following thymectomy. In vitro, OX40-deficient Treg were found to be intrinsically hyporesponsive to IL-2, in terms of Stat5 phosphorylation and proliferation, according to elevated SOCS1 content and reduced miR155 expression. Therefore, OX40 is a key factor in shaping Treg sensitivity to IL-2 and promoting their proliferation and survival, toward accurate immune regulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20806292     DOI: 10.1002/eji.201040505

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  34 in total

1.  New insights on OX40 in the control of T cell immunity and immune tolerance in vivo.

Authors:  Xiang Xiao; Weihua Gong; Gulcin Demirci; Wentao Liu; Silvia Spoerl; Xiufeng Chu; D Keith Bishop; Laurence A Turka; Xian C Li
Journal:  J Immunol       Date:  2011-12-05       Impact factor: 5.422

2.  TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40.

Authors:  Ryoko Hamano; Jiaqiang Huang; Teizo Yoshimura; Joost J Oppenheim; Xin Chen
Journal:  Eur J Immunol       Date:  2011-07       Impact factor: 5.532

3.  Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation.

Authors:  Prabhakaran Kumar; Alejandra Marinelarena; Divya Raghunathan; Vandhana K Ragothaman; Shikha Saini; Palash Bhattacharya; Jilao Fan; Alan L Epstein; Ajay V Maker; Bellur S Prabhakar
Journal:  Cell Mol Immunol       Date:  2018-03-26       Impact factor: 11.530

4.  Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant.

Authors:  Victor Tkachev; Scott N Furlan; Benjamin Watkins; Daniel J Hunt; Hengqi Betty Zheng; Angela Panoskaltsis-Mortari; Kayla Betz; Melanie Brown; John B Schell; Katie Zeleski; Alison Yu; Ian Kirby; Sarah Cooley; Jeffrey S Miller; Bruce R Blazar; Duncan Casson; Phil Bland-Ward; Leslie S Kean
Journal:  Sci Transl Med       Date:  2017-09-20       Impact factor: 17.956

5.  Nasal cardiac myosin peptide treatment and OX40 blockade protect mice from acute and chronic virally-induced myocarditis.

Authors:  Georgia Fousteri; Amy Dave; Bret Morin; Shaida Omid; Michael Croft; Matthias G von Herrath
Journal:  J Autoimmun       Date:  2011-02-17       Impact factor: 7.094

6.  Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses.

Authors:  Shannon E Smith; Dominique B Hoelzinger; Ana Lucia Dominguez; Jacques Van Snick; Joseph Lustgarten
Journal:  Cancer Immunol Immunother       Date:  2011-07-26       Impact factor: 6.968

7.  Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer.

Authors:  Eleonora Timperi; Ilenia Pacella; Valeria Schinzari; Chiara Focaccetti; Luca Sacco; Francesco Farelli; Roberto Caronna; Gabriella Del Bene; Flavia Longo; Antonio Ciardi; Sergio Morelli; Anna Rita Vestri; Piero Chirletti; Vincenzo Barnaba; Silvia Piconese
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

8.  Therapeutic evaluation of ex vivo-generated versus natural regulatory T-cells in a mouse model of chronic gut inflammation.

Authors:  Fridrik Karlsson; Nicholas E Martinez; Laura Gray; Songlin Zhang; Ikuo Tsunoda; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2013-10       Impact factor: 5.325

9.  TLR4 regulates IFN-γ and IL-17 production by both thymic and induced Foxp3+ Tregs during intestinal inflammation.

Authors:  Anthony T Cao; Suxia Yao; Andrew T Stefka; Zhanju Liu; Hongwei Qin; Houpu Liu; Heather L Evans-Marin; Charles O Elson; Cathryn R Nagler; Yingzi Cong
Journal:  J Leukoc Biol       Date:  2014-07-11       Impact factor: 4.962

10.  OX40 expression in hepatocellular carcinoma is associated with a distinct immune microenvironment, specific mutation signature, and poor prognosis.

Authors:  Kunlin Xie; Lin Xu; Hao Wu; Haotian Liao; Lin Luo; Mingheng Liao; Jianping Gong; Yang Deng; Kefei Yuan; Hong Wu; Yong Zeng
Journal:  Oncoimmunology       Date:  2018-03-06       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.